Core Insights - Corbion is holding its Capital Markets Day to present its new strategy, BRIGHT 2030, aimed at leading in sustainable specialty food ingredients for preservation and nutrition [1][3] Strategic Priorities - The company aims to accelerate clean-label preservation and formulation in food to meet rising consumer demand for transparency and natural solutions [5] - Corbion plans to expand algal fermentation beyond omega-3 oils, creating new opportunities in both pet food and human nutrition [5] - Growth in Biomedical Polymers is a focus, reinforcing Corbion's presence in high-value healthcare applications [5] - A strategic ownership review of the PLA portfolio has been initiated [5] Financial Objectives (2026-2028) - The company targets organic sales growth of 3-6% per annum [5] - An adjusted EBITDA margin of approximately 18% is expected by 2028 [5] - Cumulative free cash flow is projected to reach €270 million over the period from 2026 to 2028 [5]